CWA Asset Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
CWA Asset Management Group's IRWD Position: Q3 2026 in Review
CWA Asset Management Group increased its Ironwood Pharmaceuticals (IRWD) stake by 72% in Q3 2026, buying an estimated $870K and bringing the position to 498,643 shares worth $1.98M. The position accounts for 0.06% of the portfolio, ranked #290.
CWA Asset Management Group first reported a position in IRWD in Q2 2026 and has held it in 2 quarters since. 234 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- CWA Asset Management Group held 498,643 shares of Ironwood Pharmaceuticals worth $1.98M as of Q3 2026.
- CWA Asset Management Group bought 208,277 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $870K.
- Ironwood Pharmaceuticals made up 0.06% of CWA Asset Management Group's portfolio in Q3 2026, its #290 holding.
- CWA Asset Management Group first reported a position in Ironwood Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 234 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on CWA Asset Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.